Financials, Automotive, Healthcare Feb 22, 2022 05:09 PM (GMT+8) · EqualOcean
Dorui pharmaceutical announced that ruidilian pharmaceutical, a holding subsidiary, signed a technology transfer contract with Henan University of traditional Chinese medicine, which agreed that Henan University of traditional Chinese medicine would transfer all patents and non patented technologies related to the clinical trial approval notice of "Yifei Jisheng Granule" and its new drug projects to ruidilian pharmaceutical.
Related companies: